MariaRosa Bani

5PUBLICATIONS
29CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Aug 04, 2023
Chemotherapy-induced neutropenia elicits metastasis formation in mice by promoting proliferation of disseminated tumor cells.

Massimo Russo, Nicolò Panini, Paola Fabbrizio

|Mar 30, 2023
The PARP1 Inhibitor AZD5305 Impairs Ovarian Adenocarcinoma Progression and Visceral Metastases in Patient-derived Xenografts Alone and in Combination with Carboplatin.

Giulia Dellavedova, Alessandra Decio, Laura Formenti

|Feb 12, 2022
The DNA-PK Inhibitor AZD7648 Sensitizes Patient-Derived Ovarian Cancer Xenografts to Pegylated Liposomal Doxorubicin and Olaparib Preventing Abdominal Metastases.

Alessia Anastasia, Giulia Dellavedova, Antonio Ramos-Montoya

|Feb 08, 2022
PGC1α/β Expression Predicts Therapeutic Response to Oxidative Phosphorylation Inhibition in Ovarian Cancer.

Carmen Ghilardi, Catarina Moreira-Barbosa, Laura Brunelli

|Nov 07, 2021
VEGF pathway inhibition potentiates PARP inhibitor efficacy in ovarian cancer independent of BRCA status.

Francesca Bizzaro, Ilaria Fuso Nerini, Molly A Taylor

Pageof 1

Frequent Collaborators

4 joint publications

Carmen Ghilardi

3 joint publications

Massimo Russo

3 joint publications

Laura Formenti

2 joint publications

Alessia Anastasia